A detailed history of Klp Kapitalforvaltning As transactions in Cytokinetics Inc stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 23,000 shares of CYTK stock, worth $970,830. This represents 0.01% of its overall portfolio holdings.

Number of Shares
23,000
Holding current value
$970,830
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$46.36 - $58.62 $1.07 Million - $1.35 Million
23,000 New
23,000 $1.08 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $3.97B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.